Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D OBSCN TBC1D3C TBC1D3B ARHGEF33 KNDC1 AKAP13 TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F PLCE1

5.53e-1150711219GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D OBSCN TBC1D3C TBC1D3B ARHGEF33 KNDC1 AKAP13 TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F PLCE1

5.53e-1150711219GO:0030695
GeneOntologyMolecularFunctionGTPase activator activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F

5.52e-1027911214GO:0005096
GeneOntologyMolecularFunctionenzyme activator activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNFRSF10B TBC1D3C TBC1D3B ABHD5 TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F

7.81e-0765611216GO:0008047
GeneOntologyMolecularFunctionenzyme regulator activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D OBSCN TNFRSF10B TBC1D3C TBC1D3B ARHGEF33 ABHD5 KNDC1 CCAR2 AKAP13 TBC1D3I CABIN1 TBC1D3G PREX1 TBC1D3K TBC1D3F PLCE1

3.19e-06141811223GO:0030234
GeneOntologyMolecularFunction5'-3' DNA exonuclease activity

APTX DCLRE1B EXO1

1.41e-0591123GO:0035312
GeneOntologyMolecularFunctionphorbol ester receptor activity

UNC13B UNC13C

3.12e-0521122GO:0001565
GeneOntologyMolecularFunctionnon-kinase phorbol ester receptor activity

UNC13B UNC13C

3.12e-0521122GO:0001566
GeneOntologyMolecularFunctionmolecular function activator activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNFRSF10B TBC1D3C TBC1D3B ZNF106 ABHD5 JMJD6 SEMA3B TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F

5.28e-05123311219GO:0140677
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR3DL3 KIR2DL3 KIR3DL2

9.12e-05161123GO:0023029
GeneOntologyMolecularFunction5'-3' exonuclease activity

APTX DCLRE1B EXO1

1.32e-04181123GO:0008409
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR3DL3 KIR2DL3 KIR3DL2

1.56e-04191123GO:0032394
GeneOntologyMolecularFunctionnucleosome binding

NOC2L H2AP GLYR1 SMARCC2 CABIN1

2.28e-04981125GO:0031491
GeneOntologyMolecularFunctionDNA exonuclease activity, producing 5'-phosphomonoesters

APTX DCLRE1B EXO1

3.61e-04251123GO:0016895
GeneOntologyMolecularFunctionDNA exonuclease activity

APTX DCLRE1B EXO1

4.07e-04261123GO:0004529
GeneOntologyMolecularFunctionmolecular adaptor activity

DCAF6 ANK1 ATN1 NOC2L SHANK3 ZFPM2 GLYR1 RLIM ZAR1 KIR3DL3 SMARCC2 AKAP13 EIF3B KIR2DL3 KIR3DL2 SPPL2C DDX4 CUX1

5.32e-04135611218GO:0060090
GeneOntologyMolecularFunctionguanyl-nucleotide exchange factor activity

OBSCN ARHGEF33 KNDC1 AKAP13 PREX1 PLCE1

1.94e-032311126GO:0005085
GeneOntologyBiologicalProcessactivation of GTPase activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

2.97e-1410911313GO:0090630
GeneOntologyBiologicalProcesspositive regulation of GTPase activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F

7.02e-1124411314GO:0043547
GeneOntologyBiologicalProcessregulation of GTPase activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F

4.37e-0933511314GO:0043087
GeneOntologyBiologicalProcesspositive regulation of hydrolase activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G PREX1 TBC1D3K TBC1D3F

6.03e-0749911314GO:0051345
GeneOntologyBiologicalProcessDNA repair

PDS5B RRM2B UVSSA APTX DCLRE1B TRIP12 SETD2 USP51 RAD54B EXO1 SMARCC2 FIGNL1 PRIMPOL USP47

1.24e-0564811314GO:0006281
GeneOntologyBiologicalProcessDNA damage response

FNIP2 PDS5B RRM2B UVSSA APTX DCLRE1B TRIP12 SETD2 ALKBH8 USP51 RAD54B EXO1 SMARCC2 CCAR2 FIGNL1 PRIMPOL USP47

1.81e-0595911317GO:0006974
GeneOntologyBiologicalProcesschromatin remodeling

RBM15 NOC2L TRIP12 SETD2 USP51 H2AP JMJD6 GLYR1 RLIM RAD54B SMARCC2 CABIN1 DDX4 PRIMPOL

5.40e-0574111314GO:0006338
GeneOntologyBiologicalProcessregulation of hydrolase activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G PREX1 USP47 TBC1D3K TBC1D3F

8.94e-0587811315GO:0051336
GeneOntologyBiologicalProcesschromatin organization

RBM15 NOC2L TRIP12 SETD2 USP51 H2AP JMJD6 GLYR1 RLIM RAD54B SMARCC2 CABIN1 TAL1 DDX4 PRIMPOL

1.12e-0489611315GO:0006325
GeneOntologyBiologicalProcesspositive regulation of catalytic activity

TBC1D3E AGAP5 SGSM1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNFRSF10B TBC1D3C TBC1D3B TBC1D3I TBC1D3G PREX1 PRRC1 TBC1D3K TBC1D3F

1.51e-04102811316GO:0043085
GeneOntologyBiologicalProcessdense core granule priming

UNC13B UNC13C

1.77e-0441132GO:0061789
GeneOntologyBiologicalProcessresponse to UV

NOC2L UVSSA CCAR2 N4BP1 PRIMPOL USP47

3.18e-041671136GO:0009411
GeneOntologyCellularComponentspectrin-associated cytoskeleton

ANK1 SPTBN2 EPB41

1.37e-0591163GO:0014731
GeneOntologyCellularComponentexcitatory synapse

SPTBN2 SHANK3 CNTNAP2 UNC13C PALLD

3.27e-041071165GO:0060076
DomainTBC

TBC1D3E SGSM1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

5.25e-154911211SM00164
DomainRabGAP-TBC

TBC1D3E SGSM1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

1.35e-145311211PF00566
DomainTBC_RABGAP

TBC1D3E SGSM1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

2.09e-145511211PS50086
DomainRab-GTPase-TBC_dom

TBC1D3E SGSM1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

2.09e-145511211IPR000195
DomainUnc-13

UNC13B UNC13C

1.07e-0431122IPR027080
Domainig

OBSCN SEMA3B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2 CDON

1.49e-041901127PF00047
DomainImmunoglobulin

OBSCN SEMA3B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2 CDON

1.49e-041901127IPR013151
DomainMunc13_dom-2

UNC13B UNC13C

3.52e-0451122IPR014772
DomainMembr_traf_MHD

UNC13B UNC13C

3.52e-0451122PF10540
DomainMHD2

UNC13B UNC13C

3.52e-0451122PS51259
DomainMunc13_subgr_dom-2

UNC13B UNC13C

3.52e-0451122IPR019558
DomainDUF1041

UNC13B UNC13C

3.52e-0451122SM01145
DomainDUF1041

UNC13B UNC13C

7.34e-0471122PF06292
DomainMunc13_1

UNC13B UNC13C

7.34e-0471122IPR014770
DomainCAPS_dom

UNC13B UNC13C

7.34e-0471122IPR010439
DomainMHD1

UNC13B UNC13C

7.34e-0471122PS51258
DomainRhoGEF

OBSCN ARHGEF33 AKAP13 PREX1

7.43e-04681124SM00325
DomainRhoGEF

OBSCN ARHGEF33 AKAP13 PREX1

8.29e-04701124PF00621
DomainDH_2

OBSCN ARHGEF33 AKAP13 PREX1

8.29e-04701124PS50010
DomainDH-domain

OBSCN ARHGEF33 AKAP13 PREX1

8.74e-04711124IPR000219
Domain-

OBSCN ARHGEF33 AKAP13 PREX1

8.74e-047111241.20.900.10
DomainIG

OBSCN BTN3A3 SEMA3B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2 PALLD CDON

9.80e-044211129SM00409
DomainIg_sub

OBSCN BTN3A3 SEMA3B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2 PALLD CDON

9.80e-044211129IPR003599
PathwayWP_17Q12_COPY_NUMBER_VARIATION_SYNDROME

TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K

5.51e-0999829M46448
Pubmed

TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.

TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

3.49e-28111161116863688
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.60e-0916116516403292
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.27e-0917116519218127
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.27e-0917116520878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.27e-0917116520650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.27e-0917116519450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.27e-0917116519761533
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.13e-0918116520200544
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

5.64e-0920116520193031
Pubmed

DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.

TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3B TBC1D3G TBC1D3F

5.72e-0974116716625196
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

9.52e-0922116520492596
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

UNC13B RBM15 HIVEP1 RRM2B TRIP12 FAT1 SHROOM1 AKAP13 MAP3K21 PALLD PRRC2B

3.85e-083611161126167880
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

5.70e-0812116417490516
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.13e-0735116519683555
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.15e-0714116419875891
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.15e-0714116415896204
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.15e-0714116419489269
Pubmed

PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.

TBC1D3 TBC1D3D TBC1D3F

1.44e-074116312359748
Pubmed

Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.

TBC1D3 TBC1D3D TBC1D3F

1.44e-07411638406013
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.56e-0715116420082646
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.56e-0715116419926642
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.56e-0715116420356536
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.56e-0715116420643584
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.56e-0715116417498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

1.56e-0715116419326408
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116419897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116419000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116420670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116419527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116420652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116418668235
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116419279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116417868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116418643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116419309280
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116420331834
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.07e-0716116420210919
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.70e-0717116419032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.70e-0717116420173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.70e-0717116420173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.70e-0717116420483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.70e-0717116419968064
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

PDS5B RBM15 HIVEP1 ATN1 PHRF1 GPATCH8 TRIP12 ZNF106 SETD2 EXO1 SMARCC2 CCAR2 EIF3B USP47

3.25e-077741161415302935
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.47e-0718116419630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.47e-0718116420519398
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.47e-0718116419046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.47e-0718116419846535
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.47e-0718116420580654
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

3.47e-0718116420210918
Pubmed

The Tre2 (USP6) oncogene is a hominoid-specific gene.

TBC1D3 TBC1D3D TBC1D3C

3.60e-075116312604796
Pubmed

Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.

TBC1D3 TBC1D3D TBC1D3F

3.60e-07511638471161
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

4.38e-0719116418571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

4.38e-0719116418778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

4.38e-0719116420600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of ParanĂ¡.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

4.38e-0719116418848853
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DL5B KIR3DL3 KIR2DL5A KIR3DL2

5.46e-0720116420426625
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

6.73e-0721116419861144
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CASC3 RBM15 HIVEP1 CBARP TRIP12 ZNF106 STARD9 EXO1 NHS AKAP13 MAP3K21 PALLD PRRC1 EPB41

1.15e-068611161436931259
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

FNIP2 UNC13B PDS5B GPATCH8 JMJD6 STARD9 CCAR2 ANKRD12 PRRC2B PLCE1

1.17e-064071161012693553
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR3DL3 KIR2DL3 KIR3DL2

1.25e-067116312618911
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR3DL3 KIR2DL3 KIR3DL2

1.25e-067116315748957
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR3DL3 KIR2DL3 KIR3DL2

2.00e-068116315730517
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

2.62e-0629116420082482
Pubmed

USP7 Regulates Cytokinesis through FBXO38 and KIF20B.

HIVEP1 GPATCH8 TRIP12 ZNF106 CUX1 PRRC2B

2.66e-06116116630804394
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

CASC3 HIVEP1 ATN1 SLC13A3 SHANK3 ZFPM2 SETD2 KIAA1549L GLYR1 SMARCC2 CCAR2

2.93e-065601161121653829
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR3DL3 KIR2DL5A KIR3DL2

2.99e-069116318074414
Pubmed

Human transcription factor protein interaction networks.

HIVEP1 TCF12 ATN1 GPATCH8 ZFPM2 MRPL4 FAT1 GLYR1 RLIM SMARCC2 CCAR2 N4BP1 EIF3B CABIN1 TAL1 CUX1 PRRC2B

5.38e-0614291161735140242
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SPTBN2 GPAM SHANK3 SETD2 FAM169A N4BP1 GRIN3A PREX1 PALLD UTP14C

6.38e-064931161015368895
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

PDS5B HIVEP1 GPATCH8 TRIP12 NFATC2IP GLYR1 RAD54B FAM169A SMARCC2 CABIN1 CUX1

6.39e-066081161136089195
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DL5A KIR2DL3 KIR3DL2

7.78e-0612116320137308
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DL5B KIR2DL5A KIR2DL3

1.01e-0513116319120281
Pubmed

Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism.

SHANK3 CNTNAP2

1.10e-052116232853769
Pubmed

Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres.

ANK1 OBSCN

1.10e-052116219002483
Pubmed

A novel brain-specific isoform of beta spectrin: isolation and its interaction with Munc13.

UNC13B SPTBN2

1.10e-05211629704016
Pubmed

Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.

KIR2DL5B KIR2DL5A

1.10e-052116212185535
Pubmed

Gene Expression Profiling in Trigeminal Ganglia from Cntnap2-/- and Shank3b-/- Mouse Models of Autism Spectrum Disorder.

SHANK3 CNTNAP2

1.10e-052116237699442
Pubmed

Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.

KIR2DL5B KIR2DL5A

1.10e-052116211086080
Pubmed

Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development.

ANK1 EPB41

1.10e-052116212130521
Pubmed

Mutations associated with autism lead to similar synaptic and behavioral alterations in both sexes of male and female mouse brain.

SHANK3 CNTNAP2

1.10e-052116238177238
Pubmed

β-III spectrin underpins ankyrin R function in Purkinje cell dendritic trees: protein complex critical for sodium channel activity is impaired by SCA5-associated mutations.

ANK1 SPTBN2

1.10e-052116224603075
Pubmed

Obscurin is a ligand for small ankyrin 1 in skeletal muscle.

ANK1 OBSCN

1.10e-052116212631729
Pubmed

Decreased amplitude and reliability of odor-evoked responses in two mouse models of autism.

SHANK3 CNTNAP2

1.10e-052116231891524
Pubmed

Immature Neurons and Radial Glia, But Not Astrocytes or Microglia, Are Altered in Adult Cntnap2 and Shank3 Mice, Models of Autism.

SHANK3 CNTNAP2

1.10e-052116227785461
Pubmed

Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.

KIR2DL5B KIR2DL5A

1.10e-052116217215859
Pubmed

Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses.

UNC13B UNC13C

1.10e-052116222674279
Pubmed

Gene network analysis reveals a role for striatal glutamatergic receptors in dysregulated risk-assessment behavior of autism mouse models.

SHANK3 CNTNAP2

1.10e-052116231624228
Pubmed

Mapping the binding site on small ankyrin 1 for obscurin.

ANK1 OBSCN

1.10e-052116217720975
Pubmed

Mouse model systems of autism spectrum disorder: Replicability and informatics signature.

SHANK3 CNTNAP2

1.10e-052116232445272
Pubmed

Neurodevelopmental malformations of the cerebellum and neocortex in the Shank3 and Cntnap2 mouse models of autism.

SHANK3 CNTNAP2

1.10e-052116234555490
Pubmed

Hereditary spherocytosis and hereditary elliptocytosis: aberrant protein sorting during erythroblast enucleation.

ANK1 EPB41

1.10e-052116220339087
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

PDS5B RBM15 NOC2L SPTBN2 PHRF1 TRIP12 GLYR1 SMARCC2 CCAR2 PRRC2B USP47

1.24e-056531161122586326
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR3DL3 KIR2DL5A KIR3DL2

1.28e-0514116318945962
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR3DL3 KIR2DL5A KIR2DL3

2.38e-0517116319169284
Pubmed

Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins.

SGSM1 SHROOM1 CCAR2 GRIN3A

2.60e-0551116411853319
Pubmed

The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse.

UNC13B UNC13C

3.30e-053116223658173
Pubmed

Dysregulation of Parvalbumin Expression in the Cntnap2-/- Mouse Model of Autism Spectrum Disorder.

SHANK3 CNTNAP2

3.30e-053116230116174
Pubmed

Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.

ANK1 OBSCN

3.30e-053116212527750
Pubmed

GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models.

SHANK3 CNTNAP2

3.30e-053116230282698
Pubmed

[Correlation of killer immunoglobulin-like receptor gene diversity with nasopharyngeal carcinoma in Chinese southern Han population].

KIR2DL5B KIR2DL3

3.30e-053116221729574
Pubmed

Diversity of human copy number variation and multicopy genes.

TBC1D3E TBC1D3G

3.30e-053116221030649
CytobandEnsembl 112 genes in cytogenetic band chr17q12

TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F

1.70e-1314911611chr17q12
Cytoband17q12

TBC1D3 TBC1D3H TBC1D3C TBC1D3B TBC1D3F

5.59e-0699116517q12
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DL5B KIR3DL3 KIR2DL5A KIR2DL3 KIR3DL2

6.66e-0918715620
GeneFamilyUNC13 homologs

UNC13B UNC13C

9.08e-054712836
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

OBSCN ARHGEF33 AKAP13 PREX1

1.31e-0466714722
GeneFamilyWD repeat domain containing|DDB1 and CUL4 associated factors

DCAF6 DCAF4

2.23e-0318712498
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP

HIVEP1 GPATCH8 BTN3A3 SETD2 ABHD5 JMJD6 RAD54B FAM169A N4BP1 ANKRD12 PALLD PRRC1 CUX1 PRRC2B TBC1D3F

2.56e-0682211315M6782
CoexpressionLAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM

UNC13B ANK1 SLC13A3 RNF115 ZNF804B CNTNAP2 NHS AKAP13 CUX1 CDON

1.35e-0541711310M39224
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

B4GALNT4 TBC1D3 ANK1 CCDC186 SHANK3 ZFPM2 KIAA1549L CNTNAP2 FAM169A SMARCC2 ANKRD12 GRIN3A TAL1 EPB41 PRRC2B CDON

2.14e-05110611316M39071
CoexpressionAtlasMesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F

1.13e-09901129PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlasDE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05

B4GALNT4 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F PLCE1

6.40e-0824211211PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlasEndoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F PLCE1

1.94e-0721311210PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlasEndoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F PLCE1

1.94e-0721311210PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlasMesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D CBARP TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F PLCE1

1.04e-0632011211PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlasMesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D UVSSA TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F

2.42e-0628111210PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlasMesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D UVSSA TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F

2.42e-0628111210PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlasEctoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05

TBC1D3 TBC1D3H TBC1D3L TBC1D3D CBARP TNFRSF10B TBC1D3C TBC1D3B SHANK3 FAT1 SEMA3B SMARCC2 TBC1D3G PALLD TBC1D3K CDON TBC1D3F

4.73e-05107511217PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL FAT1 CNTNAP2 NHS GRIN3A PLCE1

6.46e-07192114767d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCelldroplet-Lung-nan-18m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALNT4 RAD54B KNDC1 EXO1 FIGNL1 PRIMPOL

6.60e-06178114679823d13652177de852c2acce9159049241f1d86
ToppCellMesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor

B4GALNT4 ZFPM2 TGFBI FAT1 NHS UNC13C

9.29e-06189114644e37f88137bb249933eb615235b2cf2ae7f3925
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 CNTNAP2 NHS GRIN3A

9.57e-06190114626843ec1d19ac85a50990705353b802745d33e4d
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL CNTNAP2 NHS GRIN3A PLCE1

9.57e-061901146d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

FNIP2 OBSCN RNF115 FAT1 AKAP13 PALLD

9.57e-06190114693c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

GPC6 ABCA10 ZFPM2 CNTNAP2 CDON PLCE1

9.57e-0619011464f775ee24b14733f06ae40b45f2dc1a0f0df0705
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

TCF12 SLC13A3 GPC6 NHS AKAP13 CUX1

1.02e-051921146e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellThalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32

B4GALNT4 SPTBN2 CBARP CNTNAP2 FAM169A DNAJC5

1.05e-051931146712a4acd1167e43543950bc819ff11984e6f718d
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL CNTNAP2 NHS GRIN3A PLCE1

1.08e-0519411464f758718a1233c25c25d99fc1b7b06f906b8b0a2
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL CNTNAP2 NHS GRIN3A PLCE1

1.08e-05194114602a9cc821c2b14aa7d0e55661a5fab66364474e1
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 FAT1 CNTNAP2 NHS GRIN3A PLCE1

1.14e-0519611467af6c5147ac859353504d19727dbe24f63a29dd4
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

CCDC186 ABHD5 RLIM ANKRD12 PALLD USP47

1.25e-05199114618a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCellNeuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic

TCF12 ANK1 CNTNAP2 NHS GRIN3A PLCE1

1.28e-0520011469ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 GPC6 CNTNAP2 NHS GRIN3A PLCE1

1.28e-052001146107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GPAM ABCA10 ZFPM2 ABHD5 CDON

5.91e-051611145a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATN1 H2AP EXO1 PALLD UTP14C

6.64e-0516511450edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATN1 H2AP EXO1 PALLD UTP14C

6.64e-051651145fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor

C2CD4B OBSCN SHANK3 STARD9 TAL1

7.03e-0516711455af9127bae05768a5164d5708a4ad37edca99324
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GPAM GPATCH8 ALKBH8 KIR3DL3 SMARCC2

8.53e-051741145ccc79febfcf588d8294ffc712338be96de8a5033
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DCLRE1B TNFRSF10B GPC6 TGFBI KIAA1549L

8.76e-0517511451d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DCLRE1B TNFRSF10B GPC6 TGFBI KIAA1549L

8.76e-051751145427a7ee92fe16a90625946492062d37aa0f7235b
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 NHS PLCE1

8.76e-0517511459d797888edb39fd12fd9cfc698a42b7bed19a5b5
ToppCellsevere-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

TBC1D3L TMEM119 NHS PREX1 EPB41

9.24e-051771145d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 NHS PLCE1

9.75e-051791145d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 NHS PLCE1

1.08e-041831145121791ef84e7ce377ed6f5b7953af8865e04958e
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 OBSCN FAT1 UNC13C PLCE1

1.11e-0418411452cbed6462fea2622871bb7e49b0df3d984239281
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 NHS PLCE1

1.11e-0418411452ba98708dfd7f1b2a661578a334684094ff453ad
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

HIVEP1 GPC6 TBC1D3C NHS AKAP13

1.11e-041841145d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 OBSCN FAT1 UNC13C PLCE1

1.11e-041841145ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK1 OBSCN FAT1 UNC13C PLCE1

1.11e-0418411452b19a8c5f823e00812908b23e66bb4e563278aff
ToppCelldroplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 TNFRSF10B SHANK3 ALKBH8 PLCE1

1.14e-0418511456a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ANK1 CNTNAP2 NHS GRIN3A GPRASP2

1.14e-041851145739260f8abebaf10a5cc49d91726278579e26170
ToppCelldroplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 TNFRSF10B SHANK3 ALKBH8 PLCE1

1.14e-04185114564791056cdbb739136dbef08f4b16e2b5427faad
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 NHS PLCE1

1.14e-041851145f4ac62009c0ad3346e71b809e17727303c4df153
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL FAT1 NHS GRIN3A

1.17e-041861145948815663c212c4311329d503b5991cbbbff9808
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 GPC6 CNTNAP2 NHS GRIN3A

1.20e-04187114585f1678338a47d91e296f0620d4887f057eb7e70
ToppCellCerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32

CBARP CNTNAP2 FAM169A DNAJC5 ANKRD12

1.20e-04187114561b9d6eb131a674598aa8409d7fa909c8765442d
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ZFPM2 TGFBI FAT1 NHS UNC13C

1.20e-041871145c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL NHS GRIN3A PLCE1

1.26e-04189114578cf414b98bcb19deb934409acddaad1cd51b67f
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

FNIP2 OBSCN RNF115 AKAP13 PALLD

1.26e-0418911450a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellGlobus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

B4GALNT4 SPTBN2 CBARP CNTNAP2 ANKRD12

1.29e-041901145416de85d8841dac883faa6f5339b2fb461a09e82
ToppCellCV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster

MRPL4 EXO1 EIF3B MAP3K21 DCAF4

1.35e-041921145a249787f7e2f50af49bd7d4752c411a067a5e3d3
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

GPC6 ZFPM2 FAT1 NHS PALLD

1.35e-04192114567e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCellEntopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32

SGSM1 SPTBN2 CNTNAP2 DNAJC5 ANKRD12

1.35e-0419211454c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL GPC6 NHS PLCE1

1.35e-0419211450003d7ef9a8e521e70ac33c63aad843d9b6215c2
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 CNTNAP2 NHS GRIN3A PLCE1

1.35e-041921145bf1943715085c4124b1675888b0615c9500ec888
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL CNTNAP2 NHS GRIN3A

1.39e-0419311454979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCelldroplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPAM GPC6 FAT1 SHROOM1 CDON

1.39e-04193114564edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCelldroplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM119 GPC6 TGFBI UNC13C PALLD

1.39e-0419311452d891c00b8f0aace17d4c300b63e2341dcffa199
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 CNTNAP2 NHS GRIN3A PLCE1

1.39e-04193114553bcd50892c379b2a571751f6eb1062436339fe7
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

GPC6 ZFPM2 FAT1 NHS PALLD

1.39e-0419311455de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TMEM119 ZFPM2 UNC13C PALLD PLCE1

1.42e-04194114535f132cc38ac133be01834ed0946188aa0757eb4
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANK1 MYRFL CNTNAP2 NHS GRIN3A

1.42e-041941145e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCellPCW_10-12-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

C2CD4B SHANK3 SHROOM1 TAL1 PREX1

1.49e-0419611450e8d649b50be2d707510b897bb97767b5847dff9
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

CCDC186 TRIP12 RLIM ANKRD12 USP47

1.60e-041991145fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TCF12 ZFPM2 TGFBI FAT1 PALLD

1.60e-04199114538cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCellkidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

GPATCH8 FAT1 AKAP13 CABIN1 UTP14C

1.60e-041991145174f6013af6eafa577f84205a62927f2b367fda3
ToppCellNeuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

TCF12 MYRFL FAT1 UNC13C GRIN3A

1.64e-042001145ca5401b76ab014080914bf78042d368cf318effa
ToppCellHematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

UNC13B SHANK3 ZFPM2 SHROOM1 SEMA3B

1.64e-042001145032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 MYRFL GPC6 CNTNAP2 PLCE1

1.64e-0420011453cbb01039d1e7635ec4dcdf0223587f7ea3c7b34
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 GPC6 CNTNAP2 NHS PLCE1

1.64e-0420011454a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type

ZFPM2 TGFBI FAT1 DMP1 PALLD

1.64e-042001145c5e051f1aac8dda376c342a9932785a23450e073
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

ZFPM2 TGFBI FAT1 DMP1 PALLD

1.64e-0420011459d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 MYRFL GPC6 CNTNAP2 PLCE1

1.64e-04200114597a010a1b6d551239cf6ea5a43319fb413ff180e
ToppCellHematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

UNC13B SHANK3 ZFPM2 SHROOM1 SEMA3B

1.64e-04200114568fce28690246895fd33354b30960ebcc31aa4cc
ToppCellwk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

TMEM119 GPC6 ABCA10 CNTNAP2 PALLD

1.64e-042001145d769723f8fcb37d9b86589e0c41c1d7f16393cfe
ToppCellHematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

UNC13B SHANK3 ZFPM2 SHROOM1 SEMA3B

1.64e-042001145376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCellNeuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

TCF12 MYRFL FAT1 UNC13C GRIN3A

1.64e-04200114570c47d3bbe67d88c5b9dff99c33a603d25fa2ab0
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TRIP12 SETD2 AKAP13 ANKRD12 EPB41

1.64e-04200114512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ZFPM2 TGFBI FAT1 DMP1 PALLD

1.64e-042001145c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCellNeuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic

TCF12 ANK1 FAT1 NHS GRIN3A

1.64e-0420011455ef4a3dc18a44292184a59ced916183c0699b01e
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 MYRFL GPC6 CNTNAP2 PLCE1

1.64e-0420011458ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672
ToppCellNeuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic

TCF12 MYRFL FAT1 UNC13C GRIN3A

1.64e-04200114540286010bd17cf9e34ecd5440953b072ebfae208
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ZFPM2 TGFBI FAT1 DMP1 PALLD

1.64e-04200114508bf8c00eee6468215edb3611296bfc8784c4d56
ToppCellHematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

UNC13B SHANK3 ZFPM2 SHROOM1 SEMA3B

1.64e-0420011457fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCellCOVID-19|World / Disease, condition lineage and cell class

SETD2 AKAP13 N4BP1 ANKRD12 EPB41

1.64e-0420011457dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 GPC6 CNTNAP2 NHS PLCE1

1.64e-042001145fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 GPC6 CNTNAP2 NHS PLCE1

1.64e-042001145c6eda342ea0cb37d71d89dbb8d11e819e0745172
ToppCellwk_15-18-Mesenchymal-Fibroblast-intermediate_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

TMEM119 GPC6 ABCA10 CNTNAP2 PALLD

1.64e-0420011456461d25fd8fb52921b188f083fbe808535d3130b
ToppCellHematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

UNC13B SHANK3 ZFPM2 SHROOM1 SEMA3B

1.64e-042001145878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCellHematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

UNC13B SHANK3 ZFPM2 SHROOM1 SEMA3B

1.64e-0420011457136936d05ab344a560cf159684c881063b5430d
ToppCellNeuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic

ANK1 CNTNAP2 NHS GRIN3A PLCE1

1.64e-04200114545ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR3DL3 KIR2DL3

3.75e-0531052OBA_2042107
DiseaseCCL4 measurement

TBC1D3 SETD2 TBC1D3F

4.78e-05201053EFO_0004751
Diseasemacrophage inflammatory protein 1b measurement

TBC1D3 TBC1D3B SETD2 ABHD5 TBC1D3F

1.29e-041361055EFO_0008219
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

PDS5B HIVEP1 JAKMIP3 TRIP12 LY6K TAL1 PLCE1

3.32e-043641057EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Diseasebody fat percentage

PDS5B HIVEP1 JAKMIP3 TRIP12 LY6K TAL1 PRRC2B PLCE1

3.63e-044881058EFO_0007800
Diseaseanemia (phenotype), response to ribavirin

PHRF1 ZNF804B

4.44e-0491052EFO_0004272, GO_1901559
Diseaseliver fat measurement

RBM15 GPAM CNTNAP2

4.87e-04431053EFO_0010821
Diseasememory performance

UNC13B PDS5B NOC2L GPC6 KIAA1549L ZNF804B UNC13C

6.63e-044091057EFO_0004874
DiseaseSemantic-Pragmatic Disorder

SHANK3 CNTNAP2

6.76e-04111052C0454655
DiseaseAuditory Processing Disorder, Central

SHANK3 CNTNAP2

6.76e-04111052C0751257
DiseaseLanguage Delay

SHANK3 CNTNAP2

6.76e-04111052C0023012
DiseaseLanguage Development Disorders

SHANK3 CNTNAP2

6.76e-04111052C0023014
DiseaseSpeech Delay

SHANK3 CNTNAP2

6.76e-04111052C0241210
DiseaseC-X-C motif chemokine 11 measurement

ZFPM2 CUX1

1.11e-03141052EFO_0008057
DiseaseIntellectual Disability

ATN1 RRM2B SHANK3 SETD2 ALKBH8 RLIM SMARCC2

1.11e-034471057C3714756
Diseaseresponse to olanzapine

HIVEP1 ZFPM2

1.28e-03151052GO_0097333
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR3DL3 KIR2DL3

1.28e-03151052EFO_0801746
DiseaseGlobal developmental delay

ATN1 SPTBN2 ALKBH8 SMARCC2

1.33e-031331054C0557874
Diseasepreeclampsia, hypertension, pregnancy-induced

PREX1 PLCE1

1.46e-03161052EFO_0000668, MONDO_0024664
DiseaseUterine leiomyoma, estrogen-receptor positive breast cancer

ZFPM2 EXO1

1.85e-03181052EFO_1000649, HP_0000131
Diseaseautism spectrum disorder (implicated_via_orthology)

SHANK3 CNTNAP2 PREX1 GPRASP2

2.16e-031521054DOID:0060041 (implicated_via_orthology)
Diseasefree androgen index

FNIP2 CASC3 TCF12 ZFPM2 SETD2 CUX1

2.24e-033741056EFO_0007005
DiseaseRS-6-hydroxywarfarin measurement

SGSM1 KIR3DL3 N4BP1 GRIN3A

2.32e-031551054EFO_0803328
DiseaseAntihypertensive use measurement

ZFPM2 THAP3 PREX1 CDH16 PLCE1

2.62e-032651055EFO_0009927
Diseaseblood pressure

GPC6 PREX1

2.77e-03221052EFO_0004325
DiseaseAutism Spectrum Disorders

TRIP12 SHANK3 CNTNAP2

3.50e-03851053C1510586

Protein segments in the cluster

PeptideGeneStartEntry
ANRPQERGDELADSA

TGFBI

636

Q15582
QAPDALEQAADTSRR

CCAR2

466

Q8N163
LEQAADTSRRNAETP

CCAR2

471

Q8N163
RQRAASESTEQEEGD

CBARP

336

Q8N350
SSAETQPAQEELRED

EPB41

151

P11171
RDSEDRSDSRAAQPA

DCAF4

26

Q8WV16
NARSSAEDRSPENTG

CCDC186

731

Q7Z3E2
EAPGEQARDERSDSR

EIF3B

106

P55884
SEDQRSVQRAEEPRD

BTN3A3

356

O00478
TRESQAAAREDNDPN

CXorf49;

386

A8MYA2
RESSNDCEDNPTRNR

DDX4

111

Q9NQI0
EIDDFRNRNGSDDPS

ABCA10

851

Q8WWZ4
RDSASSVPRINDSQE

ALKBH8

551

Q96BT7
SAVQPERRNAASSEE

CUX1

826

P39880
PEAESSQADRDRRQQ

ANK1

1766

P16157
DGSSDPRDIDQDNRS

ATN1

116

P54259
SRSREESADAPVDQN

AKAP13

571

Q12802
ERESEQTSFSDQNPR

ARHGEF33

796

A8MVX0
RSGNSDSIERDAAQE

APTX

131

Q7Z2E3
ESERERDGEQSPNVS

DCAF6

326

Q58WW2
VSDNSLNRSPRSENE

ANKRD12

1181

Q6UB98
SPEESADQSQADRDS

DCLRE1B

356

Q9H816
NLPSEESTREINNRD

RAD54B

66

Q9Y620
VDEISPEDDQRANRT

RBM15

361

Q96T37
RAQQRAESPESSAIE

PDS5B

1351

Q9NTI5
EPAGDRTVNRQDSDE

KIR3DL2

376

P43630
RTVNREDSDDQDPQE

KIR2DL5A

281

Q8N109
NTPESNRDESFVIDR

FAT1

2741

Q14517
DSLPNSAHDRDRTQD

FIGNL1

161

Q6PIW4
SAHDRDRTQDFPESN

FIGNL1

166

Q6PIW4
SLSPAAVADNVERAD

JMJD6

36

Q6NYC1
TDDEAPRLSQNGDRQ

LAD1

41

O00515
TSQDREREVDNNREP

H2AP

81

O75409
EREVDNNREPHSAES

H2AP

86

O75409
RDPEDSQRTDEGDNR

LY6K

26

Q17RY6
EPAGNRTVNREDSDE

KIR2DL3

281

P43628
RQREAAPVSEENEDS

ZFPM2

276

Q8WW38
NEDEERRAGSESPAR

C2CD4B

206

A6NLJ0
RTVNREDSDDQDPQE

KIR2DL5B

281

Q8NHK3
QDDSQRRSLPAEEGS

GPATCH8

751

Q9UKJ3
AGNRTVNREDSDEQD

KIR3DL3

361

Q8N743
RTSSTNEDEDLNPEQ

TCF12

556

Q99081
RNSSEERSRPNSGDE

GLYR1

111

Q49A26
RSSEVQDPDSEGQNR

MYRFL

191

Q96LU7
NLQESESSAPAEDRA

PHRF1

1406

Q9P1Y6
RPSSLNDLDQSQDER

JAKMIP3

381

Q5VZ66
RRAQGQADESSENEE

JRKL

451

Q9Y4A0
RDAPQERDVAQDGST

KIAA1549L

1261

Q6ZVL6
EAQLQSDEREATDTP

DNAJC5

156

Q9H3Z4
QSDDPESIRSERGNS

DMP1

216

Q13316
ESENSPQAETREARE

NOC2L

31

Q9Y3T9
SRAPDDSRAGAQRDE

GRIN3A

66

Q8TCU5
ESQSEEQQEARAESP

OBSCN

7231

Q5VST9
SRSRDSGDENEPIQE

PALLD

1116

Q8WX93
DPDRREVDSSAAQRG

GPC6

521

Q9Y625
RQRASQDTEDEESGA

CASC3

6

O15234
PRRDGEAQEAASETQ

CABIN1

2076

Q9Y6J0
ASEAADVAQDPQVSR

FNIP2

751

Q9P278
AETVTLPDAAQNDDR

CDON

526

Q4KMG0
EAVDQSDGSRQAPRT

CRYBG2

116

Q8N1P7
DESSDRDARPALETQ

FAM169A

396

Q9Y6X4
ASVARDQPALAQEES

KNDC1

686

Q76NI1
APATNARDSSSRVDN

CNTNAP2

1021

Q9UHC6
ARDSSSRVDNAPDQQ

CNTNAP2

1026

Q9UHC6
DPSQESEENTAAVRR

SLC13A3

171

Q8WWT9
VEAQDTDEPRLSASA

CDH16

636

O75309
TDEADETRSNETQNP

PRIMPOL

481

Q96LW4
DEEVSDPTSAAAQLR

UVSSA

451

Q2YD98
ASNPADVSDLRADDQ

TEX55

91

Q96M34
LSSSPLDQDNRANER

RNF115

91

Q9Y4L5
EEAARATENPEQVAS

MRPL4

26

Q9BYD3
DPEQDAAAAAESVRR

MAP3K21

156

Q5TCX8
QEIDSDESPVARERN

NHS

411

Q6T4R5
RSRSGSDPQDINEQE

PLCE1

1116

Q9P212
RSDPQLEGRDAAEAS

TAL1

11

P17542
RDAAEELNASSRPQT

GPRASP2

476

Q96D09
RPSDAADEGRDTSIN

GPAM

436

Q9HCL2
ADEGRDTSINESRNA

GPAM

441

Q9HCL2
QEARASQEASTEDPS

PREX1

796

Q8TCU6
ISENEATNPEDRSDS

SPPL2C

586

Q8IUH8
ARAASDSDPDEQASL

SHROOM1

731

Q2M3G4
QEDPRITRGQDEASA

PRRC1

196

Q96M27
SPRQTDDTVFRDSEA

STARD9

2116

Q9P2P6
TDSDQGTPFRARDEQ

TBC1D3L

511

B9A6J9
DNSNSDSEGEDRRPA

NFATC2IP

86

Q8NCF5
TLTDEVNSPDSDRRD

SMARCC2

276

Q8TAQ2
VDTDVARNSSDDIPN

EXO1

551

Q9UQ84
SRPRFDSDAEEVENQ

ABHD5

116

Q8WTS1
AAPSTQRAEDSSESR

B4GALNT4

66

Q76KP1
TQRDADRSLSIPDEQ

AGAP5

176

A6NIR3
RPEAAGLDQDERSSS

RRM2B

6

Q7LG56
TDSDQGTPFRARDEQ

TBC1D3B

511

A6NDS4
TDSDQGTPFRARDEQ

TBC1D3H

511

P0C7X1
DSQNPERADSTVSRD

USP51

526

Q70EK9
RSELNQDAEPASSQE

UTP14C

431

Q5TAP6
ASESRNDQDSAIPRT

ZNF804B

986

A4D1E1
RSQSELQSDDSEDAP

UNC13C

761

Q8NB66
DAQERPRDVSSADLV

SPTBN2

1931

O15020
RDRDADQESNISGPL

SHANK3

411

Q9BYB0
TDSDQGTPFRARDEQ

TBC1D3F

511

A6NER0
TQAERLARAEEAAPA

SEMA3B

666

Q13214
NSENENEPSARRSSG

RLIM

151

Q9NVW2
PLNERDSSASVDNRE

USP47

911

Q96K76
PAVAQSNSSEEEARE

PRRC2B

596

Q5JSZ5
SPDARASAAQDADSV

UNC13B

1251

O14795
TDSDQGTPFRARDEQ

TBC1D3E

511

A0A087X179
ERVDRSSQRPGAEDN

TNFRSF10B

256

O14763
PRDGSVDDRQSSEAT

SGSM1

806

Q2NKQ1
DRTQGQVPDSLTDDR

SETD2

1321

Q9BYW2
TDSDQGTPFRARDEQ

TBC1D3D

511

A0A087WVF3
VRENTDPASERGNAS

THAP3

91

Q8WTV1
EINQSDSQDSRVAPR

TRIP12

1571

Q14669
TDSDQGTPFRARDEQ

TBC1D3G

511

Q6DHY5
TDSDQGTPFRARDEQ

TBC1D3

511

Q8IZP1
RPEEALDSSRQLQAD

TMEM119

161

Q4V9L6
EPSNSNQEINSDDRR

ZNF106

86

Q9H2Y7
AARDENDTIPSVDTS

HIVEP1

2281

P15822
TDSDQGTPFRARDEQ

TBC1D3K

511

A0A087X1G2
TDSDQGTPFRARDEQ

TBC1D3I

511

A0A087WXS9
TDSDQGTPFRARDEQ

TBC1D3C

511

Q6IPX1
RPQSDDDGEAQAAVR

ZAR1

236

Q86SH2
PAQRSSAETNELREA

N4BP1

846

O75113